リコンビナント
RabMAb

Anti-CD38 抗体 [EPR4106] (ab108403)

ab108403 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab108403 は 4 報の論文で使用されています。

  • Esch MB  et al. Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow. Lab Chip 15:2269-77 (2015). PubMed: 25857666
  • Ceroni F  et al. A deletion involving CD38 and BST1 results in a fusion transcript in a patient with autism and asthma. Autism Res 7:254-63 (2014). PubMed: 24634087
  • Chini CC  et al. Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumors. Clin Cancer Res 20:120-30 (2014). WB ; Human . PubMed: 24025713
  • Kobayashi M  et al. Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis. World J Gastroenterol 20:3597-608 (2014). IHC-P ; Human . PubMed: 24707143

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録